| Name | Cvs Pharmacy #05068 |
|---|---|
| Organization Name | Warm Springs Road Cvs, L.l.c. |
| Location | 9405 W Russell Rd, Las Vegas, Nevada 89148 |
| Type | Pharmacy |
| Phone | (702) 262-7854 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
Anti-aging supplements made up of mixtures might be better than single compounds at preventing decline in physical function, according to researchers at the University of Florida's Institute on Aging. In addition, it appears that such so-called neutraceuticals should be taken before very old age for benefits such as improvement in physical function.
A question long debated among Alzheimer's disease researchers has been definitively answered by scientists at the Gladstone Institute of Neurological Disease in San Francisco.
Some patients with metastatic renal cell carcinoma who are switched from a traditional sunitinib treatment schedule to an alternative schedule fare better on survival measures and suffer fewer adverse events, a Japanese study has found.
› Verified 9 days ago
| NPI Number | 1558460865 |
| Organization Name | WARM SPRINGS ROAD CVS, L.L.C. |
| Doing Business As | CVS PHARMACY #05068 |
| Type | Pharmacy |
| Address | 9405 W Russell Rd, Las Vegas, NV 89148 |
| Phone Number | 702-262-7854 |
News Archive
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
Anti-aging supplements made up of mixtures might be better than single compounds at preventing decline in physical function, according to researchers at the University of Florida's Institute on Aging. In addition, it appears that such so-called neutraceuticals should be taken before very old age for benefits such as improvement in physical function.
A question long debated among Alzheimer's disease researchers has been definitively answered by scientists at the Gladstone Institute of Neurological Disease in San Francisco.
Some patients with metastatic renal cell carcinoma who are switched from a traditional sunitinib treatment schedule to an alternative schedule fare better on survival measures and suffer fewer adverse events, a Japanese study has found.
› Verified 9 days ago
News Archive
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
Anti-aging supplements made up of mixtures might be better than single compounds at preventing decline in physical function, according to researchers at the University of Florida's Institute on Aging. In addition, it appears that such so-called neutraceuticals should be taken before very old age for benefits such as improvement in physical function.
A question long debated among Alzheimer's disease researchers has been definitively answered by scientists at the Gladstone Institute of Neurological Disease in San Francisco.
Some patients with metastatic renal cell carcinoma who are switched from a traditional sunitinib treatment schedule to an alternative schedule fare better on survival measures and suffer fewer adverse events, a Japanese study has found.
› Verified 9 days ago
A-class Medical Supplies Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5460 Cameron St, Las Vegas, Nevada 89118 Phone: (702) 462-2247 | |
Accredo Health Group Inc Type: Pharmacy Location: 1335 E Sunset Rd, Las Vegas, Nevada 89119 Phone: (702) 895-8990 | |
Qhr Pharmacy Type: Community/Retail Pharmacy Location: 7512 Westcliff Dr, Las Vegas, Nevada 89145 Phone: (702) 331-6796 | |
Advanced Prosthetics & Orthotics In Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7455 W. Washington Ave, Las Vegas, Nevada 89128 Phone: (702) 256-5265 | |
Aeva Specialty Pharmacy Type: Pharmacy Location: 6280 S Valley View Blvd, Las Vegas, Nevada 89118 Phone: (702) 558-2382 |